CoChat
Sign Up
Cited by 102

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Engineered nanoparticles for imaging and drug delivery in colorectal cancer

Pavitra, Eluri, Dariya, Begum, Srivani, Gowru, Kang, Sung-Min, Alam, Afroz, Sudhir, Putty-Reddy, Kamal, Mohammad Amjad, Raju, Ganji Seeta Rama, Han, Young-Kyu, Lakkakula, Bhaskar Venkata Kameswara Subrahmanya, Nagaraju, Ganji Purnachandra, Huh, Yun Suk·2021·Seminars in Cancer Biology
DOI 10.1016/j.semcancer.2019.06.017
Open this paper in CoChat — free account

Abstract

Colorectal cancer (CRC) is one of the deadliest diseases worldwide due to a lack of early detection methods and appropriate drug delivery strategies. Conventional imaging techniques cannot accurately distinguish benign from malignant tissue, leading to frequent misdiagnosis or diagnosis at late stages of the disease. Novel screening tools with improved accuracy and diagnostic precision are thus required to reduce the mortality burden of this malignancy. Additionally, current therapeutic strategies, including radio- and chemotherapies carry adverse side effects and are limited by the development of drug resistance. Recent advances in nanotechnology have rendered it an attractive approach for designing novel clinical solutions for CRC. Nanoparticle-based formulations could assist early tumor detection and help to overcome the limitations of conventional therapies including poor aqueous solubility, nonspecific biodistribution and limited bioavailability. In this review, we shed light on various types of nanoparticles used for diagnosis and drug delivery in CRC. In addition, we will explore how these nanoparticles can improve diagnostic accuracy and promote selective drug targeting to tumor sites with increased efficiency and reduced cytotoxicity against healthy colon tissue.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.semcancer.2019.06.017

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 161

  1. Siegel, 2019, Cancer statistics, CA: A Cancer J. Clin., 69, 7
  2. Yallapu, 2013, Curcumin nanomedicine: a road to cancer therapeutics, Curr. Pharm. Des., 19, 1994
  3. Bose, 2015, Curcumin and tumor immune-editing: resurrecting the immune system, Cell Div., 10, 6, 10.1186/s13008-015-0012-z · DOI
  4. Yallapu, 2015, Therapeutic applications of curcumin nanoformulations, AAPS J., 17, 1341, 10.1208/s12248-015-9811-z · DOI
  5. Krais, 2014, Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum, Nanomedicine: NBM, 10, 1421, 10.1016/j.nano.2014.01.006 · DOI
  6. Landmark, 2008, Synthesis, characterization, and in vitro testing of superparamagnetic iron oxide nanoparticles targeted using folic acid-conjugated dendrimers, ACS Nano, 2, 773, 10.1021/nn800034w · DOI
  7. Liu, 2009, Carbon nanotubes in biology and medicine: in vitro and in vivo detection, imaging and drug delivery, Nano Res., 2, 85, 10.1007/s12274-009-9009-8 · DOI
  8. Gatoo, 2014, Physicochemical properties of nanomaterials: implication in associated toxic manifestations, Biomed Res. Int., 2014, 8, 10.1155/2014/498420 · DOI
  9. Rizvi, 2018, Applications of nanoparticle systems in drug delivery technology, Saudi Pharm. J., 26, 64, 10.1016/j.jsps.2017.10.012 · DOI
  10. Owens, 2006, opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles, Int. J. Pharm., 307, 93, 10.1016/j.ijpharm.2005.10.010 · DOI · Paper page
  11. Petros, 2010, Strategies in the design of nanoparticles for therapeutic applications, Nat. Rev. Drug Discov., 9, 615, 10.1038/nrd2591 · DOI · Paper page
  12. Chen, 1973, The role of the sinus wall in the passage of erythrocytes through the spleen, Blood, 41, 529, 10.1182/blood.V41.4.529.529 · DOI
  13. Rampersaud, 2016, The Effect of Cage Shape on Nanoparticle-Based Drug Carriers: Anticancer Drug Release and Efficacy via Receptor Blockade Using Dextran-Coated Iron Oxide Nanocages, Nano Lett., 16, 7357, 10.1021/acs.nanolett.6b02577 · DOI
  14. Chithrani, 2007, Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes, Nano Lett., 7, 1542, 10.1021/nl070363y · DOI
  15. Xie, 2017, The effect of shape on cellular uptake of gold nanoparticles in the forms of stars, rods, and triangles, Sci. Rep., 7, 3827, 10.1038/s41598-017-04229-z · DOI
  16. Nambara, 2016, Reverse size dependences of the cellular uptake of triangular and spherical gold nanoparticles, Langmuir, 32, 12559, 10.1021/acs.langmuir.6b02064 · DOI
  17. Peng, 2017, Impacts of interfacial charge transfer on nanoparticle electrocatalytic activity towards oxygen reduction, Phys. Chem. Chem. Phys., 19, 9336, 10.1039/C6CP08925A · DOI
  18. Forest, 2017, Preferential binding of positive nanoparticles on cell membranes is due to electrostatic interactions: a too simplistic explanation that does not take into account the nanoparticle protein corona, Mater. Sci. Eng. C, 70, 889, 10.1016/j.msec.2016.09.016 · DOI
  19. Graf, 2012, Surface functionalization of silica nanoparticles supports colloidal stability in physiological media and facilitates internalization in cells, Langmuir, 28, 7598, 10.1021/la204913t · DOI
  20. Huhn, 2013, Polymer-coated nanoparticles interacting with proteins and cells: focusing on the sign of the net charge, ACS Nano, 7, 3253, 10.1021/nn3059295 · DOI
  21. Barua, 2014, Challenges associated with penetration of nanoparticles across cell and tissue barriers: a review of current status and future prospects, Nano Today, 9, 223, 10.1016/j.nantod.2014.04.008 · DOI
  22. Lee, 2007, A protein nanocarrier from charge-conversion polymer in response to endosomal pH, J. Am. Chem. Soc., 129, 5362, 10.1021/ja071090b · DOI
  23. Yuan, 2012, Surface charge switchable nanoparticles based on zwitterionic polymer for enhanced drug delivery to tumor, Adv. Mater., 24, 5476, 10.1002/adma.201202296 · DOI
  24. Han, 2012, Enhanced siRNA delivery and silencing gold–chitosan nanosystem with surface charge-reversal polymer assembly and good biocompatibility, ACS Nano, 6, 7340, 10.1021/nn3024688 · DOI
  25. Hyun, 2018, Surface modification of polymer nanoparticles with native albumin for enhancing drug delivery to solid tumors, Biomaterials, 180, 206, 10.1016/j.biomaterials.2018.07.024 · DOI
  26. Mao, 2016, Functional nanoparticles for magnetic resonance imaging, Wiley Interdiscip, Rev.: Nanomed. Nanobiotechnol., 8, 814
  27. Cheng, 2014, Multifunctional nanoparticles for brain tumor imaging and therapy, Adv. Drug Delivery Rev., 66, 42, 10.1016/j.addr.2013.09.006 · DOI
  28. Shahbazi, 2016, Oligonucleotide-based theranostic nanoparticles in cancer therapy, Nanomedicine (London U.K), 11, 1287, 10.2217/nnm-2016-0035 · DOI
  29. Latorre, 2014, Single-point mutation detection in RNA extracts using gold nanoparticles modified with hydrophobic molecular beacon-like structures, Chem. Commun. (Cambridge, U. K.), 50, 3018, 10.1039/C3CC47862A · DOI
  30. Souza, 2018, Pre- and postoperative imaging methods in colorectal cancer, Arq. Bras. Cir. Dig., 31, 10.1590/0102-672020180001e1371 · DOI
  31. Yee, 2014, ACR appropriateness criteria colorectal cancer screening, JACR, 11, 543
  32. Hüneburg, 2016, Colonoscopy detects significantly more flat adenomas than 3-tesla magnetic resonance colonography: a pilot trial, Endosc. Int. Open, 4, E164, 10.1055/s-0041-111501 · DOI
  33. Mizukami, 2011, Diffusion-weighted magnetic resonance imaging for detecting lymph node metastasis of rectal cancer, World J. Surg., 35, 895, 10.1007/s00268-011-0986-x · DOI
  34. Bor, 2016, Role of ultrasound in colorectal diseases, World J. Gastroenterol., 22, 9477, 10.3748/wjg.v22.i43.9477 · DOI
  35. Meta, 2001, Impact of 18F-FDG PET on managing patients with colorectal cancer: the referring physician’s perspective, J. Nucl. Med., 42, 586
  36. Sakuma, 2011, Lectin-immobilized fluorescent nanospheres for targeting to colorectal cancer from a physicochemical perspective, Curr. Drug. Discovery. Technol., 8, 367, 10.2174/157016311798109407 · DOI
  37. Zheng, 2007, Sensitivity map of laser tweezers Raman spectroscopy for single-cell analysis of colorectal cancer, J. Biomed. Opt., 12
  38. Lin, 2011, Colorectal cancer detection by gold nanoparticle based surface-enhanced Raman spectroscopy of blood serum and statistical analysis, Opt. Express, 19, 13565, 10.1364/OE.19.013565 · DOI
  39. da Paz, 2012, Anti-CEA loaded maghemite nanoparticles as a theragnostic device for colorectal cancer, Int. J. Nanomed. Nanosurg., 7, 5271
  40. Gazouli, 2014, Quantum dots-bevacizumab complexes for in vivo imaging of tumors, In Vivo (Brooklyn), 28, 1091
  41. Guo, 2010, Multifunctional nanocarriers for cell imaging, drug delivery, and near-IR photothermal therapy, Langmuir, 26, 5428, 10.1021/la903893n · DOI
  42. Guilford, 2008, Natural products as inhibitors of carcinogenesis, Expert opin, Invest. Drugs, 17, 1341, 10.1517/13543784.17.9.1341 · DOI
  43. Zheng, 2016, Spices for prevention and treatment of cancers, Nutrients, 8, 495, 10.3390/nu8080495 · DOI
  44. Bachmeier, 2018, The role of curcumin in prevention and management of metastatic disease, Int. J. Mol. Sci., 19, 1716, 10.3390/ijms19061716 · DOI
  45. Batra, 2019, Curcumin in combination with anti-cancer drugs: a nanomedicine review, Pharmacol. Res., 139, 91, 10.1016/j.phrs.2018.11.005 · DOI
  46. Sesarman, 2018, Anti-angiogenic and anti-inflammatory effects of long-circulating liposomes co-encapsulating curcumin and doxorubicin on C26 murine colon cancer cells, Pharmacol. Rep., 70, 331, 10.1016/j.pharep.2017.10.004 · DOI
  47. Li, 2007, Liposomal curcumin with and without oxaliplatin: effects on cell growth, apoptosis, and angiogenesis in colorectal cancer, Mol. Cancer Ther., 6, 1276, 10.1158/1535-7163.MCT-06-0556 · DOI
  48. Tefas, 2017, Development of antiproliferative long-circulating liposomes co-encapsulating doxorubicin and curcumin, through the use of a quality-by-design approach, Drug Des., Dev. Ther., 11, 1605, 10.2147/DDDT.S129008 · DOI
  49. Chen, 2019, AW/O emulsion mediated film dispersion method for curcumin encapsulated pH-sensitive liposomes in the colon tumor treatment, Drug Dev. Ind. Pharm., 45, 282, 10.1080/03639045.2018.1539099 · DOI
  50. Gou, 2011, Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo, Nanoscale, 3, 1558, 10.1039/c0nr00758g · DOI
  51. Abouzeid, 2013, Anti-cancer activity of anti-GLUT1 antibody-targeted polymeric micelles co-loaded with curcumin and doxorubicin, J. Drug Targeting, 21, 994, 10.3109/1061186X.2013.840639 · DOI
  52. Raveendran, 2013, In vitro cytotoxicity and cellular uptake of curcumin-loaded Pluronic/Polycaprolactone micelles in colorectal adenocarcinoma cells, J. Biomater. Appl., 27, 811, 10.1177/0885328211427473 · DOI
  53. Chang, 2016, Curcumin-loading-dependent stability of PEGMEMA-based micelles affects endocytosis and exocytosis in colon carcinoma cells, J. Mol. Pharm. Org. Process Res., 13, 924
  54. Javadi, 2018, Curcumin mediated down‐regulation of αVβ3 integrin and up‐regulation of pyruvate dehydrogenase kinase 4 (PDK4) in Erlotinib resistant SW480 colon cancer cells, Phytother. Res., 32, 355, 10.1002/ptr.5984 · DOI
  55. Gao, 2013, Improving the anti-colon cancer activity of curcumin with biodegradable nano-micelles, J. Mater. Chem. B Mater. Biol. Med., 1, 5778, 10.1039/c3tb21091j · DOI
  56. Xu, 2018, Supramolecular nanofibers of curcumin for highly amplified radiosensitization of colorectal cancers to ionizing radiation, Adv. Funct. Mater., 28, 10.1002/adfm.201707140 · DOI
  57. Kim, 2016, Rapidly cycling Lgr5+ stem cells are exquisitely sensitive to extrinsic dietary factors that modulate colon cancer risk, Cell Death Dis., 7, e2460, 10.1038/cddis.2016.269 · DOI
  58. Chuah, 2014, Using Nanoparticle Tracking Analysis (NTA) to decipher mucoadhesion propensity of curcumin-containing chitosan nanoparticles and curcumin release, J. Dispersion Sci. Technol., 35, 1201, 10.1080/01932691.2013.800458 · DOI
  59. Li, 2014, Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cells, Int. J. Nanomed. Nanosurg., 9, 1083
  60. Anitha, 2014, In vitro combinatorial anticancer effects of 5-fluorouracil and curcumin loaded N, O-carboxymethyl chitosan nanoparticles toward colon cancer and in vivo pharmacokinetic studies, Eur. J. Pharm. Biopharm., 88, 238, 10.1016/j.ejpb.2014.04.017 · DOI
  61. Xiao, 2015, Hyaluronic acid-functionalized polymeric nanoparticles for colon cancer-targeted combination chemotherapy, Nanoscale, 7, 17745, 10.1039/C5NR04831A · DOI · Paper page
  62. Xiao, 2015, Co-delivery of camptothecin and curcumin by cationic polymeric nanoparticles for synergistic colon cancer combination chemotherapy, J. Mater. Chem. B Mater. Biol. Med., 3, 7724, 10.1039/C5TB01245G · DOI
  63. Chaurasia, 2016, Curcumin-polymeric nanoparticles against colon-26 tumor-bearing mice: cytotoxicity, pharmacokinetic and anticancer efficacy studies, Drug Dev. Ind. Pharm., 42, 694, 10.3109/03639045.2015.1064941 · DOI
  64. Xie, 2017, Supercritical carbon dioxide-developed silk fibroin nanoplatform for smart colon cancer therapy, Int. J. Nanomed. Nanosurg., 12, 7751, 10.2147/IJN.S145012 · DOI
  65. Rao, 2015, Curcumin encapsulated pH sensitive gelatin based interpenetrating polymeric network nanogels for anti cancer drug delivery, Int. J. Pharm., 478, 788, 10.1016/j.ijpharm.2014.12.001 · DOI
  66. Rejinold, 2015, Anti-cancer, pharmacokinetics and tumor localization studies of pH-, RF-and thermo-responsive nanoparticles, Int. J. Biol. Macromol., 74, 249, 10.1016/j.ijbiomac.2014.11.044 · DOI
  67. Dash, 2017, Selection and optimization of nano‐formulation of P‐glycoprotein inhibitor for reversal of doxorubicin resistance in COLO 205 cells, J. Pharm. Pharmacol., 69, 834, 10.1111/jphp.12722 · DOI
  68. Marjaneh, 2018, Phytosomal curcumin inhibits tumor growth in colitis‐associated colorectal cancer, J. Cell. Physiol., 233, 6785, 10.1002/jcp.26538 · DOI
  69. Wong, 2019, Curcumin nanoformulations for colorectal cancer: a Review, Front. Pharmacol., 10, 10.3389/fphar.2019.00152 · DOI
  70. San Hipólito-Luengo, 2017, Dual effects of resveratrol on cell death and proliferation of Colon Cancer cells, Nutr. Cancer, 69, 1019, 10.1080/01635581.2017.1359309 · DOI
  71. Soo, 2016, Enhancing delivery and cytotoxicity of resveratrol through a dual nanoencapsulation approach, J. Colloid Interface Sci., 462, 368, 10.1016/j.jcis.2015.10.022 · DOI
  72. Summerlin, 2016, Colloidal mesoporous silica nanoparticles enhance the biological activity of resveratrol, Colloids Surf. B Biointerfaces, 144, 1, 10.1016/j.colsurfb.2016.03.076 · DOI
  73. Feng, 2017, Enhanced antitumor efficacy of resveratrol-loaded nanocapsules in colon cancer cells: physicochemical and biological characterization, Eur. Rev. Med. Pharmacol. Sci., 21, 375
  74. Kamal, 2018, Physiological uptake and retention of radiolabeled resveratrol loaded gold nanoparticles ((99m)Tc-Res-AuNP) in colon cancer tissue, Nanomedicine, 14, 1059, 10.1016/j.nano.2018.01.008 · DOI
  75. Serini, 2018, Omega-3 PUFA loaded in resveratrol-based solid lipid nanoparticles: physicochemical properties and antineoplastic activities in human colorectal Cancer cells in vitro, Int. J. Mol. Sci., 19, 586, 10.3390/ijms19020586 · DOI
  76. Calviello, 2005, Docosahexaenoic acid enhances the susceptibility of human colorectal cancer cells to 5-fluorouracil, Cancer chemother, Pharmacol., 55, 12
  77. Serini, 2016, How plausible is the use of dietary n-3 PUFA in the adjuvant therapy of cancer?, Nutr. Res. Rev., 29, 102, 10.1017/S0954422416000044 · DOI
  78. Santandreu, 2011, Resveratrol potentiates the cytotoxic oxidative stress induced by chemotherapy in human colon cancer cells, Cell. Physiol. Biochem., 28, 219, 10.1159/000331733 · DOI
  79. Mohapatra, 2011, 5-fluorouracil increases the chemopreventive potentials of resveratrol through DNA damage and MAPK signaling pathway in human colorectal cancer cells, Oncol. Res., 19, 311, 10.3727/096504011X13079697132844 · DOI
  80. Gumireddy, 2019, Preparation, Characterization, and In vitro Evaluation of Curcumin- and Resveratrol-Loaded Solid Lipid Nanoparticles, AAPS PharmSciTech, 20, 145, 10.1208/s12249-019-1349-4 · DOI
  81. Spagnuolo, 2015, Genistein and cancer: current status, challenges, and future directions, Adv. Nutr., 6, 408, 10.3945/an.114.008052 · DOI
  82. Pool, 2018, Development of genistein-PEGylated silica hybrid nanomaterials with enhanced antioxidant and antiproliferative properties on HT29 human colon cancer cells, Am. J. Transl. Res., 10, 2306
  83. Merchant, 2011, Molecular basis of the anti-cancer effects of genistein isoflavone in LNCaP prostate cancer cells, Funct. Foods Health Dis., 1, 91, 10.31989/ffhd.v1i3.137 · DOI
  84. Li, 1999, Induction of apoptosis in breast cancer cells MDA-MB-231 by genistein, Oncogene, 18, 3166, 10.1038/sj.onc.1202650 · DOI
  85. Baxa, 2003, Genistein reduces NF-κB in T lymphoma cells via a caspase-mediated cleavage of IκBα, Biochem. Pharmacol., 66, 1009, 10.1016/S0006-2952(03)00415-5 · DOI
  86. Pham, 2015, Mitochondriotropic nanoemulsified genistein-loaded vehicles for cancer therapy, MIMB, 1265, 85
  87. des Rieux, 2005, Transport of nanoparticles across an in vitro model of the human intestinal follicle associated epithelium, Eur. J. Pharm. Sci., 25, 455, 10.1016/j.ejps.2005.04.015 · DOI
  88. Sohaebuddin, 2010, Nanomaterial cytotoxicity is composition, size, and cell type dependent, Part. Fibre Toxicol., 7, 22, 10.1186/1743-8977-7-22 · DOI
  89. Albanese, 2012, The effect of nanoparticle size, shape, and surface chemistry on biological systems, Annu. Rev. Biomed. Eng., 14, 1, 10.1146/annurev-bioeng-071811-150124 · DOI
  90. Bannunah, 2014, Mechanisms of nanoparticle internalization and transport across an intestinal epithelial cell model: effect of size and surface charge, J. Mol. Pharm. Org. Process Res., 11, 4363
  91. Gekle, 1999, Inhibition of Na+‐H+ exchange impairs receptor‐mediated albumin endocytosis in renal proximal tubule‐derived epithelial cells from opossum, J. Physiol. (Paris), 520, 709
  92. Del Gaudio, 2017, Nanospray drying as a novel tool to improve technological properties of soy isoflavone extracts, Planta Med., 83, 426
  93. Zduńska, 2018, Antioxidant properties of ferulic acid and its possible application, Skin Pharmacol. Physiol., 31, 332, 10.1159/000491755 · DOI
  94. de Oliveira, 2015, Ferulic acid: a key component in grass lignocellulose recalcitrance to hydrolysis, Plant Biotechnol. J., 13, 1224, 10.1111/pbi.12292 · DOI
  95. Zheng, 2019, Poly(Ferulic acid) with an anticancer effect as a drug nanocarrier for enhanced Colon Cancer therapy, Adv. Funct. Mater., 29, 10.1002/adfm.201808646 · DOI
  96. Roy, 2016, Plant phenolics ferulic acid and p-coumaric acid inhibit colorectal cancer cell proliferation through EGFR down-regulation, Asian Pac. J. Cancer Prev., 17, 4019
  97. Sara, 2018, 5-fluorouracil and cardiotoxicity: a review, Ther. Adv. Med. Oncol., 10, 10.1177/1758835918780140 · DOI
  98. Escalante, 2017, Impact of chemotherapy on gastrointestinal functions and the enteric nervous system, Maturitas, 105, 23, 10.1016/j.maturitas.2017.04.021 · DOI
  99. Wang, 2008, Templated synthesis of single-component polymer capsules and their application in drug delivery, Nano Lett., 8, 1741, 10.1021/nl080877c · DOI
  100. Ochs, 2010, Biodegradable click capsules with engineered drug-loaded multilayers, ACS Nano, 4, 1653, 10.1021/nn9014278 · DOI
  101. Ariga, 2012, Forming nanomaterials as layered functional structures toward materials nanoarchitectonics, NPG Asia Mater., 4, 10.1038/am.2012.30 · DOI
  102. Correa, 2016, Engineering nanolayered particles for modular drug delivery, J. Control. Release, 240, 364, 10.1016/j.jconrel.2016.01.040 · DOI
  103. Sivakumar, 2009, Monodisperse polymer-encapsulated emulsions as anticancer drug carriers, Adv. Mater., 21, 1820, 10.1002/adma.200802475 · DOI
  104. Chen, 2014, Effective inhibition of colon cancer cell growth with MgAl-layered double hydroxide (LDH) loaded 5-FU and PI3K/mTOR dual inhibitor BEZ-235 through apoptotic pathways, Int. J. Nanomed. Nanosurg., 9, 3403
  105. Ghasemi, 2015, Aptamer decorated hyaluronan/chitosan nanoparticles for targeted delivery of 5-fluorouracil to MUC1 overexpressing adenocarcinomas, Carbohydr. Polym., 121, 190, 10.1016/j.carbpol.2014.12.025 · DOI
  106. Li, 2013, The upregulation of dihydropyrimidine dehydrogenase in liver is involved in acquired resistance to 5-fluorouracil, Eur. J. Cancer (Oxford, England : 1990, 49, 1752, 10.1016/j.ejca.2012.12.013 · DOI
  107. Negrei, 2016, Colon Cancer cells gene expression signature As response to 5- fluorouracil, oxaliplatin, and folinic acid treatment, Front. Pharmacol., 7, 10.3389/fphar.2016.00172 · DOI
  108. Chen, 2015, Overcoming acquired drug resistance in colorectal cancer cells by targeted delivery of 5-FU with EGF grafted hollow mesoporous silica nanoparticles, Nanoscale, 7, 14080, 10.1039/C5NR03527A · DOI
  109. Shakeri-Zadeh, 2001, Combination of ultrasound and newly synthesized magnetic nanocapsules affects the temperature profile of CT26 tumors in BALB/c mice, J. Med. Ultrason. (2001), 42, 9, 10.1007/s10396-014-0558-4 · DOI
  110. Udofot, 2016, Pharmacokinetic, biodistribution and therapeutic efficacy of 5-fluorouracil-loaded pH-sensitive PEGylated liposomal nanoparticles in HCT-116 tumor bearing mouse, JNSCI, 2
  111. Safwat, 2016, Gold nanoparticles enhance 5-fluorouracil anticancer efficacy against colorectal cancer cells, Int. J. Pharm., 513, 648, 10.1016/j.ijpharm.2016.09.076 · DOI · Paper page
  112. Russo, 2016, Enhancement of 5-FU sensitivity by the proapoptotic rpL3 gene in p53 null colon cancer cells through combined polymer nanoparticles, Oncotarget, 7, 79670, 10.18632/oncotarget.13216 · DOI
  113. Pan, 2017, Mesoporous silica nanoparticles (MSNs)-based organic/inorganic hybrid nanocarriers loading 5-Fluorouracil for the treatment of colon cancer with improved anticancer efficacy, Colloids Surf. B Biointerfaces, 159, 375, 10.1016/j.colsurfb.2017.08.013 · DOI
  114. Jiang, 2018, Hyaluronidase enzyme-responsive targeted nanoparticles for effective delivery of 5-Fluorouracil in Colon Cancer, Pharm. Res., 35, 73, 10.1007/s11095-017-2302-4 · DOI
  115. Pan, 2017, Mesoporous silica nanoparticles (MSNs)-based organic/inorganic hybrid nanocarriers loading 5-Fluorouracil for the treatment of colon cancer with improved anticancer efficacy, Colloids Surf. B Biointerfaces, 159, 375, 10.1016/j.colsurfb.2017.08.013 · DOI
  116. Ramalakshmi, 2016, Molecular markers for capecitabine therapy: a review, Int. J. Pharm. Sci. Res., 7, 4315
  117. Hirsch, 2011, Capecitabine in the management of colorectal cancer, Cancer Manage. Res., 3, 79
  118. Nabavizadeh, 2016, Evaluation of nanocarrier targeted drug delivery of Capecitabine-PAMAM dendrimer complex in a mice colorectal Cancer model, Acta Med. Iran., 54, 485
  119. Dudhipala, 2018, Capecitabine lipid nanoparticles for anti-colon cancer activity in 1,2-dimethylhydrazine-induced colon cancer: preparation, cytotoxic, pharmacokinetic, and pathological evaluation, Drug Dev. Ind. Pharm., 44, 1572, 10.1080/03639045.2018.1445264 · DOI
  120. Cohen, 2007, FDA drug approval summary: bevacizumab plus FOLFOX4 as second-line treatment of colorectal cancer, Oncologist, 12, 356, 10.1634/theoncologist.12-3-356 · DOI
  121. Pangeni, 2016, Multiple nanoemulsion system for an oral combinational delivery of oxaliplatin and 5-fluorouracil: preparation and in vivo evaluation, Int. J. Nanomed. Nanosurg., 11, 6379, 10.2147/IJN.S121114 · DOI
  122. Wang, 2011, Oxaliplatin-incorporated micelles eliminate both cancer stem-like and bulk cell populations in colorectal cancer, Int. J. Nanomedicine, 6, 3207
  123. Li, 2010, Therapeutic effectiveness of slow-release PLGA-oxaliplatin microsphere on human colorectal tumor-bearing mice, Anticancer Drugs, 21, 600, 10.1097/CAD.0b013e3283393004 · DOI
  124. Wu, 2013, PEGylated multi-walled carbon nanotubes for encapsulation and sustained release of oxaliplatin, Pharm. Res., 30, 412, 10.1007/s11095-012-0883-5 · DOI
  125. Maksimenko, 2014, Therapeutic modalities of Squalenoyl Nanocomposites in Colon Cancer: an ongoing search for improved efficacy, ACS Nano, 8, 2018, 10.1021/nn500517a · DOI
  126. Guo, 2015, Paclitaxel and gemcitabine combinational drug-loaded mucoadhesive delivery system in the treatment of colon cancers, Drug Res., 65, 199
  127. Zhao, 2018, Gold nanoparticles enhance cisplatin delivery and potentiate chemotherapy by decompressing colorectal cancer vessels, Int. J. Nanomedicine, 13, 6207, 10.2147/IJN.S176928 · DOI · Paper page
  128. Simón-Gracia, 2016, Paclitaxel-loaded polymersomes for enhanced intraperitoneal chemotherapy, Mol. Cancer Ther., 15, 670, 10.1158/1535-7163.MCT-15-0713-T · DOI
  129. Xu, 2016, Thermosensitive hydrogel system assembled by PTX-loaded copolymer nanoparticles for sustained intraperitoneal chemotherapy of peritoneal carcinomatosis, Eur. J. Pharm. Biopharm., 104, 251, 10.1016/j.ejpb.2016.05.010 · DOI
  130. Fan, 2014, Docetaxel load biodegradable porous microspheres for the treatment of colorectal peritoneal carcinomatosis, Int. J. Biol. Macromol., 69, 100, 10.1016/j.ijbiomac.2014.05.026 · DOI
  131. Yun, 2017, Use of 5-Fluorouracil loaded micelles and cisplatin in Thermosensitive Chitosan Hydrogel as an efficient therapy against colorectal peritoneal carcinomatosis, Macromol. Biosci., 17, 10.1002/mabi.201600262 · DOI
  132. Cunningham, 2001, Optimizing the use of irinotecan in colorectal cancer, Oncologist, 6, 17, 10.1634/theoncologist.6-suppl_4-17 · DOI
  133. Einafshar, 2018, New cyclodextrin-based nanocarriers for drug delivery and phototherapy using an irinotecan metabolite, Carbohydr. Polym., 194, 103, 10.1016/j.carbpol.2018.03.102 · DOI
  134. Pai, 2006, Prospects of RNA interference therapy for cancer, Gene Ther., 13, 464, 10.1038/sj.gt.3302694 · DOI
  135. Torrecilla, 2014, Lipid nanoparticles as carriers for RNAi against viral infections: current status and future perspectives, Biomed Res. Int., 2014, 17, 10.1155/2014/161794 · DOI
  136. Kang, 2017, Oral siRNA delivery to treat colorectal liver metastases, ACS Nano, 11, 10417, 10.1021/acsnano.7b05547 · DOI
  137. Javan, 2018, Hypoxia-inducible bidirectional shRNA expression vector delivery using PEI/chitosan-TBA copolymers for colorectal Cancer gene therapy, Life Sci., 202, 140, 10.1016/j.lfs.2018.04.011 · DOI
  138. Gupta, 2018, Polyamino acid layer-by-Layer (LbL) constructed silica-supported mesoporous titania nanocarriers for stimuli-responsive delivery of microRNA 708 and paclitaxel for combined chemotherapy, ACS Appl. Mater. Interfaces, 10, 24392, 10.1021/acsami.8b06642 · DOI
  139. Tirella, 2019, CD44 targeted delivery of siRNA by using HA-decorated nanotechnologies for KRAS silencing in cancer treatment, Int. J. Pharm., 561, 114, 10.1016/j.ijpharm.2019.02.032 · DOI · Paper page
  140. Li, 2018, Targeted delivery of anti-miR-155 by functionalized mesoporous silica nanoparticles for colorectal cancer therapy, Int. J. Nanomed. Nanosurg., 13, 1241, 10.2147/IJN.S158290 · DOI
  141. Grifantini, 2018, Magnetically driven drug delivery systems improving targeted immunotherapy for colon-rectal cancer, J. Control. Release, 280, 76, 10.1016/j.jconrel.2018.04.052 · DOI
  142. Van der Jeught, 2018, Drug resistance and new therapies in colorectal cancer, World J. Gastroenterol., 24, 3834, 10.3748/wjg.v24.i34.3834 · DOI · Paper page
  143. Feng, 2018, Binary cooperative prodrug nanoparticles improve immunotherapy by synergistically modulating immune tumor microenvironment, Adv. Mater., 30, 10.1002/adma.201803001 · DOI
  144. Kumar, 2012, Glutathione-mediated release of Bodipy® from PEG cofunctionalized gold nanoparticles, Int. J. Nanomed. Nanosurg., 7, 4007, 10.2147/IJN.S33726 · DOI
  145. Wang, 2013, Novel shell-cross-linked micelles with detachable PEG corona for glutathione-mediated intracellular drug delivery, Soft Matter, 9, 692, 10.1039/C2SM27028E · DOI
  146. Gao, 2019, Engineering nanoparticles for targeted remodeling of the tumor microenvironment to improve Cancer immunotherapy, Theranostics, 9, 126, 10.7150/thno.29431 · DOI
  147. Prendergast, 2017, Discovery of IDO1 inhibitors: from bench to bedside, Cancer Res., 77, 6795, 10.1158/0008-5472.CAN-17-2285 · DOI
  148. Meir, 2017, Fast image-guided stratification using anti-programmed death ligand 1 gold nanoparticles for Cancer immunotherapy, ACS Nano, 11, 11127, 10.1021/acsnano.7b05299 · DOI
  149. Li, 2018, Dual targeting delivery of miR-328 by functionalized mesoporous silica nanoparticles for colorectal cancer therapy, Nanomedicine (Lond), 13, 30084727, 10.2217/nnm-2017-0353 · DOI
  150. Amenta, 2015, Carbon nanotubes: potential medical applications and safety concerns, Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol., 7, 371, 10.1002/wnan.1317 · DOI
  151. Lee, 2013, Targeting colorectal cancer cells with single-walled carbon nanotubes conjugated to anticancer agent SN-38 and EGFR antibody, Biomaterials, 34, 8756, 10.1016/j.biomaterials.2013.07.067 · DOI
  152. Lin, 2011, Pharmacodynamic modeling of anti-cancer activity of tetraiodothyroacetic acid in a perfused cell culture system, PLoS Comput. Biol., 7, 10.1371/journal.pcbi.1001073 · DOI
  153. Li, 2018, EGFR-targeted liposomal nanohybrid cerasomes: theranostic function and immune checkpoint inhibition in a mouse model of colorectal cancer, Nanoscale, 10, 16738, 10.1039/C8NR05803B · DOI
  154. Cabrera-García, 2016, Gd-Si oxide nanoparticles as contrast agents in magnetic resonance imaging, Nanomaterials Basel (Basel), 6, 109, 10.3390/nano6060109 · DOI
  155. Yaghoubi, 2019, PD-1/ PD-L1 blockade as a novel treatment for colorectal cancer, Biomed. Pharmacother., 110, 312, 10.1016/j.biopha.2018.11.105 · DOI
  156. Hameed, 2018, Cerasomes and Bicelles: Hybrid Bilayered Nanostructures With Silica-Like Surface in Cancer Theranostics, Front. Chem., 6, 10.3389/fchem.2018.00127 · DOI
  157. Wrobel, 2019, Current status of immunotherapy in metastatic colorectal cancer, Int. J. Colorectal Disease, 34, 13, 10.1007/s00384-018-3202-8 · DOI
  158. Vyas, 2008, The known unknowns of antigen processing and presentation, Nat. Rev. Immunol., 8, 607, 10.1038/nri2368 · DOI
  159. Bobisse, 2016, Neoantigen-based cancer immunotherapy, Ann. Transl. Med., 4, 262, 10.21037/atm.2016.06.17 · DOI
  160. Goodwin, 2017, Investigation of phosphorylated adjuvants co-encapsulated with a model cancer peptide antigen for the treatment of colorectal cancer and liver metastasis, Vaccine, 35, 2550, 10.1016/j.vaccine.2017.03.067 · DOI
  161. Heße, 2019, A tumor-peptide based nanoparticle vaccine elicits efficient tumor growth control in anti-tumor immunotherapy, Mol. Cancer Ther., 10.1158/1535-7163.MCT-18-0764 · DOI

Cited by

Sorted by citations

See all 102

Metadata

Authors
Pavitra, E., Dariya, B., Srivani, G., Kang, S.-M., Alam, A., Sudhir, P.-R., Kamal, M. A., Raju, G. S. R., Han, Y.-K., Lakkakula, B. V. K. S., Nagaraju, G. P., & Huh, Y. S.
Venue
Seminars in Cancer Biology
Publisher
Elsevier BV
Published
2021-02
Volume
69
Pages
293-306
ISSN
1044-579X
DOI
10.1016/j.semcancer.2019.06.017
Cited by
102
References
3
Language
en
Licence
Funders
National Research Foundation of Korea

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review